Cargando…
Targeting ESM1/ VEGFα signaling axis: a promising therapeutic avenue for angiogenesis in cervical squamous cell carcinoma
Background: Endothelial-specific molecule 1 (ESM1) dysregulation is widespread in various malignancies. However, the exact significance of ESM1 in cervical squamous cell carcinoma (CSCC) is not yet well understood. Methods: The expression of ESM1 in CSCC was probed by immunohistochemistry (IHC) assa...
Autores principales: | Li, Dan, Su, Xiaomin, Xue, Shen, Yao, Li, Yu, Dan, Tang, Xianbing, Huang, Yugang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10355198/ https://www.ncbi.nlm.nih.gov/pubmed/37476182 http://dx.doi.org/10.7150/jca.84654 |
Ejemplares similares
-
ESM1 Is a Promising Therapeutic Target and Prognostic Indicator for Esophageal Carcinogenesis/Esophageal Squamous Cell Carcinoma
por: Li, Juan, et al.
Publicado: (2022) -
Promising avenues of therapeutics for bipolar illness
por: Post, Robert M.
Publicado: (2008) -
Practical ESM analysis
por: Robertson, Sue
Publicado: (2019) -
Novel specific anti‐ESM1 antibodies overcome tumor bevacizumab resistance by suppressing angiogenesis and metastasis
por: Kang, Nannan, et al.
Publicado: (2023) -
Identification of ESM1 overexpressed in head and neck squamous cell carcinoma
por: Xu, Hongbo, et al.
Publicado: (2019)